Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -512,300 | -1,630,500 | -897,300 | 145,500 | 96,700 |
| Depreciation Amortization | 1,492,600 | 3,901,400 | 2,603,900 | 1,160,700 | 608,500 |
| Income taxes - deferred | -304,300 | -690,100 | -412,500 | -151,500 | -149,900 |
| Accounts receivable | -702,100 | -611,100 | -365,600 | -162,900 | -113,600 |
| Other Working Capital | -422,000 | -431,900 | -454,300 | -363,100 | -122,400 |
| Other Operating Activity | 973,100 | 1,705,200 | 957,200 | 280,400 | 120,300 |
| Operating Cash Flow | $525,000 | $2,243,000 | $1,431,400 | $909,100 | $439,600 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 790,500 | N/A | N/A | 18,000 | N/A |
| PPE Investments | -61,700 | -224,900 | -162,100 | -76,600 | -39,100 |
| Net Acquisitions | -34,646,200 | -5,562,300 | -4,922,600 | -119,200 | N/A |
| Purchase Of Investment | -15,000 | -1,000 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 453,700 | 452,700 | N/A | 15,000 |
| Purchase Sale Intangibles | -8,500 | -36,100 | -100 | N/A | N/A |
| Other Investing Activity | -8,500 | -36,100 | -100 | 0 | 0 |
| Investing Cash Flow | $-33,940,900 | $-5,370,600 | $-4,632,100 | $-177,800 | $-24,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 29,265,600 | 9,356,200 | 8,156,200 | 3,756,200 | N/A |
| Debt Repayment | -2,660,000 | -6,127,000 | -4,875,500 | -467,800 | -326,100 |
| Common Stock Issued | 4,113,700 | 105,900 | 43,300 | 8,100 | 6,400 |
| Common Stock Repurchased | -64,100 | -130,100 | -99,700 | -59,400 | -57,000 |
| Other Financing Activity | 4,630,400 | -187,500 | -48,100 | -37,000 | 8,700 |
| Financing Cash Flow | $35,285,600 | $3,017,500 | $3,176,200 | $3,200,100 | $-368,000 |
| Exchange Rate Effect | -4,800 | -5,900 | -2,100 | -3,800 | -1,900 |
| Beginning Cash Position | 250,000 | 329,000 | 329,000 | 329,000 | 329,000 |
| End Cash Position | 2,114,900 | 250,000 | 339,400 | 4,293,600 | 337,700 |
| Net Cash Flow | $1,864,900 | $-79,000 | $10,400 | $3,964,600 | $8,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 525,000 | 2,243,000 | 1,431,400 | 909,100 | 439,600 |
| Capital Expenditure | -136,600 | -238,600 | -174,100 | -80,800 | -42,500 |
| Free Cash Flow | 388,400 | 2,004,400 | 1,257,300 | 828,300 | 397,100 |